Synthesis of sparteine-like chiral diamines and evaluation in the enantioselective lithiation-substitution of N-(tert-butoxycarbonyl)pyrrolidine

被引:64
作者
Hermet, JPR
Porter, DW
Dearden, MJ
Harrison, JR
Koplin, T
O'Brien, P [1 ]
Parmene, J
Tyurin, V
Whitwood, AC
Gilday, J
Smith, NM
机构
[1] Univ York, Dept Chem, York YO10 5DD, N Yorkshire, England
[2] AstraZeneca, Proc R&D, Avlon Works, Bristol BS10 7ZE, Avon, England
[3] GlaxoSmithKline, Med Res Ctr, Stevenage SG1 2NY, Herts, England
关键词
D O I
10.1039/b308410h
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
Three chiral diamines were synthesised and evaluated as sparteine surrogates in the lithiation-substitution of N-(tert-butoxycarbonyl)pyrrolidine. The synthesis and attempted resolution of sparteine-like diamines {(1S*, 2R*, 8R*)-10-methyl-6,10-diazatricyclo[6.3.1.0(2,6)]dodecane and (1S*, 2R*, 9R*)-11-methyl-7,11-diazatricyclo[7.3.1.0(2,7)]tridecane} ( via inclusion complex formation) are reported. Unfortunately, it was only possible to resolve the diazatricyclo[7.3.1.0(2,7)] tridecane compound. An alternative route to (1R, 2S, 9S)-11-methyl-7,11-diazatricyclo[ 7.3.1.0(2,7)]tridecane starting from the natural product, (-)-cytisine, is described. This simple three-step route furnished gram-quantities of a (+)-sparteine surrogate. X-Ray crystallography of an intermediate in the route, (1R, 5S, 12S)-3-methoxycarbonyl-decahydro-1,5-methanopyrido[1,2-a][1,5]diazocin-8-one, enabled the stereochemistry of all of the tricyclic diamines described in this paper to be unequivocally established. Two other diamines, starting from (S)-proline and resolved 2-piperidine ethanol, were prepared using standard methods. These diamines lacked the bispidine framework of (-)-sparteine and were found to impart vastly inferior enantioselectivity. It was concluded that, for the asymmetric lithiation-substitution of N-Boc pyrrolidine, a rigid bispidine framework and only three of the four rings of (-)-sparteine are needed for high enantioselectivity. Furthermore, it is shown that diamine (1R, 2S, 9S)-11-methyl-7,11-diazatricyclo[7.3.1.0(2,7)]tridecane is the first successful (+)-sparteine surrogate.
引用
收藏
页码:3977 / 3988
页数:12
相关论文
共 99 条